When paired with anticancer medications, caffeic acid increased apoptosis and suppressed the growth and clonogenicity of acid-adapted cancer cells by inhibiting the hyperactivation of the PI3K/Akt and ERK1/2 signalling pathways linked to drug resistance. This evidence concerns the gene MAPK3 and cancer.